Competent Cells Market by Type (Cloned Competent Cells, Agrobacterium Tumefaciens Competent Cells, and Expression Competent Cells), Treatment (Chemically Competent Cells and Electrocompetent Cells), Application (Cloning, Protein Expression, others), and by End User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, and Contract Research Organizations)- Global Opportunity Analysis and Industry Forecasts to 2023
Global competent cells market is expected to
reach USD 2,318.6 million by 2023, at a CAGR of 10.0% during the forecast
period of 2018 to 2023.
Succeeding an extensive secondary and primary research on
competent cells and in-depth analysis of the market scenario, the report
carries out an impact analysis of the key industry drivers, restraint,
opportunities, and challenges in the market dynamics segment.
Transformation is a process which includes direct uptake of
DNA released into an environment by host cells and simultaneously integrates
that DNA with host genome for recombination. Naturally, many bacteria have an
ability to take up DNA from environment. The DNA provides nutrients to these
natural competent cells, while recombination leads to new genetic evolution.
This ability to take up external DNA is referred as natural competence.
However, not all bacteria are naturally competent; thereby reduces the chances
of recombinational development. Hence, by using this concept, researchers
developed artificial competence, where the cells are made competent using
induced methods such as electroporation or chemicals mediated methods.
Request to Sample
Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3723
Growing demand for recombinant proteins and molecular cloned
products, advancement in molecular cloning research with emergence of new
technologies, and various government initiatives and availability of funding
for life science research are the key drivers propelling the industry growth during
the forecast period. Moreover, emerging economies such as Latin America, Asia
Pacific, & Africa provides significant opportunity in this market. However,
factors such as high cost of cloning based research and shortage of skilled
professionals for handling of competent cells hinder the growth of this market
in many parts of the globe.
Speak To analyst:
https://www.meticulousresearch.com/speak-to-analyst/?cp_id=3723
The study offers a comprehensive analysis of competent cells
market with respect to various segments on the basis of type, treatment,
application, and end user. The competent cells market is categorized on the
basis of type (cloned competent cells, Agrobacterium tumefaciens competent
cells, and expression competent cells), treatment (chemically competent cells
and electrocompetent cells), application (cloning, protein expression, others),
and end user (pharmaceutical & biotechnology industry, academic &
research institutes, and contract research organizations). The cloned competent
cells commanded the largest share in the global competent cells market in 2017.
This is mainly attributed to rising adoption of cloned competent cells in
research with increasing feasibility of genetic therapy, growing need for rapid
diagnosis & treatment, favorable government support for cloning based
research in various countries, and rising availability of sophisticated
instruments and technology.
Further, an in-depth analysis of the geographic scenario of
the industry provides detailed qualitative and quantitative insights for the
five major geographies (North America, Europe, Asia-Pacific, Latin America, and
Middle East & Africa) along with the coverage of major countries in each
region. The geographic analysis provides detailed insights on the key trends of
the industry in the listed regions & countries, identifying the demographic
& economic impact, and government & private investments. The geographic
analysis section also comments on the key market players shaping the growth of
the industry in the respective countries. Geographically, North America
commanded the largest share in the global competent cells market in 2017. This
was due to well-established healthcare system in the region, higher acceptance
of advanced technologies, raising non-communicable diseases & related rise
in pharmaceutical research & development, increase in cloning based
research, and presence of many key players in this region.
The report also includes the competitive landscape based on
extensive assessment of the key strategic developments adopted by leading
market participants in the industry over the past 4 years (2014-2017). The key
players in the global competent cells market are Thermo Fisher Scientific,
Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck &
Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene
Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian
Bioscience, Inc., Delphi Genetics S.A., Qiagen N.V., Cell Applications, Inc.,
GenScript Biotech Corporation, and Takara Holdings Inc.
Contact Us:
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research®
Tel: +1-646-781-8004
Email: viren@meticulousresearch.com
Comments
Post a Comment